1. Home
  2. ONCY vs BRFH Comparison

ONCY vs BRFH Comparison

Compare ONCY & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCY
    SELLHOLDBUYas of 9 hours ago
  • BRFH
  • Stock Information
  • Founded
  • ONCY 1998
  • BRFH 2005
  • Country
  • ONCY Canada
  • BRFH United States
  • Employees
  • ONCY N/A
  • BRFH N/A
  • Industry
  • ONCY Pharmaceuticals and Biotechnology
  • BRFH Packaged Foods
  • Sector
  • ONCY Health Care
  • BRFH Consumer Staples
  • Exchange
  • ONCY Nasdaq
  • BRFH Nasdaq
  • Market Cap
  • ONCY 53.6M
  • BRFH 50.9M
  • IPO Year
  • ONCY 1999
  • BRFH N/A
  • Fundamental
  • Price
  • ONCY $0.54
  • BRFH $3.01
  • Analyst Decision
  • ONCY Strong Buy
  • BRFH Strong Buy
  • Analyst Count
  • ONCY 4
  • BRFH 1
  • Target Price
  • ONCY $4.00
  • BRFH $4.50
  • AVG Volume (30 Days)
  • ONCY 215.9K
  • BRFH 15.2K
  • Earning Date
  • ONCY 03-07-2025
  • BRFH 03-27-2025
  • Dividend Yield
  • ONCY N/A
  • BRFH N/A
  • EPS Growth
  • ONCY N/A
  • BRFH N/A
  • EPS
  • ONCY N/A
  • BRFH N/A
  • Revenue
  • ONCY N/A
  • BRFH $10,717,000.00
  • Revenue This Year
  • ONCY N/A
  • BRFH $51.72
  • Revenue Next Year
  • ONCY N/A
  • BRFH $38.85
  • P/E Ratio
  • ONCY N/A
  • BRFH N/A
  • Revenue Growth
  • ONCY N/A
  • BRFH 31.87
  • 52 Week Low
  • ONCY $0.53
  • BRFH $1.03
  • 52 Week High
  • ONCY $1.53
  • BRFH $4.61
  • Technical
  • Relative Strength Index (RSI)
  • ONCY 26.43
  • BRFH 37.93
  • Support Level
  • ONCY $0.58
  • BRFH $3.22
  • Resistance Level
  • ONCY $0.65
  • BRFH $3.35
  • Average True Range (ATR)
  • ONCY 0.03
  • BRFH 0.36
  • MACD
  • ONCY -0.00
  • BRFH -0.06
  • Stochastic Oscillator
  • ONCY 1.36
  • BRFH 18.01

Stock Price Comparison Chart: ONCY vs BRFH

ONCY
BRFH
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0123456789ONCY VS BRFH

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

About BRFH Barfresh Food Group Inc.

Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use